Company profile
UK company 12339676, incorporated on 28 November 2019.
GTL | Tissue biomarkers to transform oncology
Quantitative, fast and novel AI biomarkers for histology - with results in the context of validated clinical data.
Company number 12339676
Updated 07 Jul 2026 09:49
Financial period: 1 Dec 2023 to 30 Nov 2024
Reference milestones and recent Companies House filing stream events.
AA | Transaction MzU0MDc5MjIxN2FkaXF6a2N4
Published 25 Aug 2026 14:00
Company registered at Companies House
Ground Truth Labs operates as an online platform for managing and analysing histology data.
Ground Truth Labs' (GTL) mission is to enable the creation of shared digital histology cohorts, to support the discovery of new disease relevant features, and to make these advancements available to clinicians and scientists. By enabling a level of collaboration that is not possible today, GTL will help to advance the quality of diagnostic reporting, especially in specialty disciplines and for rare diseases. With a robust and reliable technology platform, GTL provides the underpinnings for a rapid regulatory approval necessary to help patients. This technology is paired with a business model that rewards cohort creation. GTL offers a platform for building digital cohorts and AI tools to enable quantitative reporting.
The company has just been set up and there are no notable impacts to report.
none yet
